201. Chronic Tubulo-interstitial Pyelonephritis with Retroperitoneal Fibrosis.
- Author
-
Soneja M, Achintya S, Nischal N, Ranjan P, Vyas S, Arava S, and Sharma SK
- Subjects
- Adult, Autoimmune Diseases diagnosis, Autoimmune Diseases drug therapy, Azathioprine therapeutic use, Biopsy, Chronic Disease, Fluorodeoxyglucose F18, Glucocorticoids therapeutic use, Humans, Immunoglobulin G blood, Laparoscopy, Male, Pyelonephritis drug therapy, Retroperitoneal Fibrosis therapy, Retroperitoneal Space pathology, Tomography, X-Ray Computed, Treatment Outcome, Autoimmune Diseases immunology, Immunoglobulin G immunology, Positron Emission Tomography Computed Tomography methods, Pyelonephritis pathology, Retroperitoneal Fibrosis diagnostic imaging, Retroperitoneal Fibrosis immunology
- Abstract
A large proportion of patients with retroperitoneal fibrosis (RPF) have been labelled as having idiopathic RPF historically. Recent reports of a subset of these patients having a fibro-inflammatory condition with characteristic histology and good response to therapy has helped in renewed understanding of an old disease. A 40 year old man presented with vague abdominal discomfort of 5 months duration. Ultrasound examination revealed soft tissue thickening with calcification over lower abdominal aorta. CT scan characterized the lesion as a retroperitoneal mass encasing the aorta with an associated lesion in upper pole of left kidney. A laparoscopic surgery and biopsy of the mass lesions were performed. It was reported as chronic tubulo-interstitial disease with retroperitoneal fibrosis. In the post-operative period, patient developed fever with weight loss. An 18F-FDG PET-CT done revealed FDG-avid retroperitoneal mass lesion. Serum IgG-4 levels were elevated and review of biopsy revealed features of IgG4 related disease. Patient had good response to treatment with steroids and azathioprine., (© Journal of the Association of Physicians of India 2011.)
- Published
- 2016